To include your compound in the COVID-19 Resource Center, submit it here.

Inhibiting PP2A reduces MECP2 in neuropsychiatric model

In a paper published in Science Translational Medicine, researchers showed that inhibiting protein phosphatase 2 (PP2A; PPP2CA) reduced levels of methyl CpG

Read the full 227 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE